These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12699587)

  • 1. Effect of exogenous human sodium iodide symporter expression on growth of MATLyLu cells.
    La Perle KM; Blomme EA; Capen CC; Jhiang SM
    Thyroid; 2003 Feb; 13(2):133-40. PubMed ID: 12699587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo expression and function of the sodium iodide symporter following gene transfer in the MATLyLu rat model of metastatic prostate cancer.
    La Perle KM; Shen D; Buckwalter TL; Williams B; Haynam A; Hinkle G; Pozderac R; Capen CC; Jhiang SM
    Prostate; 2002 Feb; 50(3):170-8. PubMed ID: 11813209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium iodide symporter/radioactive iodine system has more efficient antitumor effect in three-dimensional spheroids.
    Mitrofanova E; Hagan C; Qi J; Seregina T; Link C
    Anticancer Res; 2003; 23(3B):2397-404. PubMed ID: 12894520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
    Spitzweg C; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
    Cancer Res; 2000 Nov; 60(22):6526-30. PubMed ID: 11103823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
    Mitrofanova E; Unfer R; Vahanian N; Link C
    Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat sodium iodide symporter for radioiodide therapy of cancer.
    Mitrofanova E; Unfer R; Vahanian N; Daniels W; Roberson E; Seregina T; Seth P; Link C
    Clin Cancer Res; 2004 Oct; 10(20):6969-76. PubMed ID: 15501976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
    Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas.
    Cho JY; Shen DH; Yang W; Williams B; Buckwalter TL; La Perle KM; Hinkle G; Pozderac R; Kloos R; Nagaraja HN; Barth RF; Jhiang SM
    Gene Ther; 2002 Sep; 9(17):1139-45. PubMed ID: 12170377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo sodium iodide symporter gene therapy of prostate cancer.
    Spitzweg C; Dietz AB; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
    Gene Ther; 2001 Oct; 8(20):1524-31. PubMed ID: 11704812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene.
    Knoop K; Schwenk N; Schmohl K; Müller A; Zach C; Cyran C; Carlsen J; Böning G; Bartenstein P; Göke B; Wagner E; Nelson PJ; Spitzweg C
    J Nucl Med; 2015 Apr; 56(4):600-6. PubMed ID: 25745085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo radioiodide imaging and treatment of pancreatic cancer xenografts after MUC1 promoter-driven expression of the human sodium-iodide symporter.
    Chen RF; Li ZH; Pan QH; Zhou JJ; Tang QB; Yu FY; Zhou QB; Wang J; Chen JS
    Pancreatology; 2007; 7(5-6):505-13. PubMed ID: 17912014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line.
    Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Stokkel M; van der Heide D; Romijn JA
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1247-53. PubMed ID: 11889195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.
    Dwyer RM; Bergert ER; O'connor MK; Gendler SJ; Morris JC
    Clin Cancer Res; 2005 Feb; 11(4):1483-9. PubMed ID: 15746050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene.
    Groot-Wassink T; Aboagye EO; Glaser M; Lemoine NR; Vassaux G
    Hum Gene Ther; 2002 Sep; 13(14):1723-35. PubMed ID: 12396625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.
    Willhauck MJ; Sharif-Samani B; Senekowitsch-Schmidtke R; Wunderlich N; Göke B; Morris JC; Spitzweg C
    Breast Cancer Res Treat; 2008 May; 109(2):263-72. PubMed ID: 17636401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase-driven expression of the sodium iodide symporter (NIS) for in vivo radioiodide treatment of cancer: a new broad-spectrum NIS-mediated antitumor approach.
    Riesco-Eizaguirre G; De la Vieja A; Rodríguez I; Miranda S; Martín-Duque P; Vassaux G; Santisteban P
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1435-43. PubMed ID: 21697253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrocortisone and purinergic signaling stimulate sodium/iodide symporter (NIS)-mediated iodide transport in breast cancer cells.
    Dohán O; De la Vieja A; Carrasco N
    Mol Endocrinol; 2006 May; 20(5):1121-37. PubMed ID: 16439463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the sodium/iodide symporter in human prostate adenocarcinoma.
    Navarra M; Micali S; Lepore SM; Cesinaro AM; Celano M; Sighinolfi MC; De Gaetani C; Filetti S; Bianchi G; Russo D
    Urology; 2010 Apr; 75(4):773-8. PubMed ID: 19969326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose.
    Haberkorn U; Kinscherf R; Kissel M; Kübler W; Mahmut M; Sieger S; Eisenhut M; Peschke P; Altmann A
    Gene Ther; 2003 May; 10(9):774-80. PubMed ID: 12704416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective growth arrest of human colon cancer in mice, using rat sodium iodide symporter and radioiodine therapy.
    Mitrofanova E; Unfer R; Vahanian N; Kane S; Carvour M; Link C
    Hum Gene Ther; 2005 Nov; 16(11):1333-7. PubMed ID: 16259567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.